Opexa Therapeutics, Inc. (OPXA) Widens Q1 Loss to 10c/Share

Opexa Therapeutics, Inc. (NASDAQ: OPXA) reported Q1 EPS of ($0.10), versus ($0.06) reported last year.

For earnings history and earnings-related data on Opexa Therapeutics, Inc. (OPXA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• SanDisk upgraded at JPMorgan after investor day; shares climb